$ITMN Recent News Biogen, InterMune, Alkermes al
Post# of 102933
Posted On: 11/10/2013 1:33:44 PM
$ITMN Recent News
Biogen, InterMune, Alkermes all make stock waves with earnings 1:28 p.m. July 25, 2013 - Russ Britt
Hedge funds are buying these stocks 3:41 p.m. April 26, 2013 - Insider Monkey
Market post-mortem: Big biotechs spike as Street warming to firms 4:43 p.m. April 12, 2013 - Russ Britt
InterMune shares jump after U.K. regulator recommends key drug 9:44 a.m. March 21, 2013 - Russ Britt
Thursday’s biggest movers; Apple at 5-month low 5:27 p.m. Nov. 8, 2012 - Sue Chang
Wednesday’s biggest gaining and declining stocks 3:32 p.m. Oct. 3, 2012 - MarketWatch
Stocks to watch Tuesday: Nordson, Georgia Gulf 5:40 a.m. May 22, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 3:19 p.m. April 9, 2012 - Kate Gibson
InterMune: Light at the end of the tunnel? 2:31 p.m. April 9, 2012 - blogs.marketwatch.com
InterMune tumbles on study update 11:27 a.m. April 9, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining & declining stocks 3:34 p.m. March 15, 2012 - Kate Gibson
InterMune climbs on German regulatory update 11:28 a.m. March 15, 2012 - Val Brickates Kennedy
InterMune shares climb on German regulatory nod 10:16 a.m. March 15, 2012 - MarketWatch.com
InterMune slides for second day 11:58 a.m. Dec. 16, 2011 - Val Brickates Kennedy
InterMune plunges 21% in midday action 12:27 p.m. Dec. 15, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 3:36 p.m. Sept. 13, 2011 - Kate Gibson
InterMune tumbles 9% on stock offering 10:33 a.m. Sept. 13, 2011 - Val Brickates Kennedy
Stocks to watch Tuesday: Best Buy, Intersil 5:51 a.m. Sept. 13, 2011 - MarketWatch
3 biotech stocks battle the ‘Dendreon Effect’ 6:50 p.m. Aug. 18, 2011 - Val Brickates Kennedy
Biotech analysts see plunge as buying opportunity 1:35 p.m. Aug. 12, 2011 - Val Brickates Kennedy
Heavy Early Morning Activity On InterMune (ITMN) 8:47 a.m. Nov. 6, 2013 - TheStreet.com
InterMune Prices 6.5M Share Offering at $13.00/Share 8:41 p.m. Nov. 5, 2013 - benzinga.com
InterMune Announces 6.5M Share Offering 3:05 p.m. Nov. 4, 2013 - benzinga.com
10-Q: INTERMUNE INC 4:02 p.m. Nov. 1, 2013 - Edgar Online - (EDG = 10Q, 10K)
Two Speculative Biotech Stocks 10:00 a.m. Oct. 31, 2013 - RealMoney.com
Narrower-than-Expected Q3 Loss at InterMune - Analyst Blog 9:10 a.m. Oct. 31, 2013 - Zacks.com
InterMune's CEO Discusses Q3 2013 Results - Earnings Call Transcript 6:51 p.m. Oct. 30, 2013 - Seeking Alpha
InterMune, Inc. Discusses Q3 2013 Results (Webcast) 3:25 p.m. Oct. 30, 2013 - Seeking Alpha
Will Pfizer (PFE) Disappoint this Earnings? - Analyst Blog 11:50 a.m. Oct. 28, 2013 - Zacks.com
Jim Cramer: Buy Facebook, Express, and This Hot Stock 8:34 a.m. Sept. 13, 2013 - Wall St. Cheat Sheet
Cramer's Lightning Round - We Bought A Ton Of Facebook (9/12/13) 2:57 a.m. Sept. 13, 2013 - Seeking Alpha
UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013 6:40 a.m. Sept. 4, 2013 - 247WallSt.com
10-Q: INTERMUNE INC 4:18 p.m. Aug. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
InterMune Successfully Entering Huge Niche Market Unchallenged 9:37 a.m. July 28, 2013 - Seeking Alpha
Narrower-than-Expected Loss at InterMune - Analyst Blog 4:29 p.m. July 25, 2013 - Zacks.com
UPDATE: Stifel Nicolaus Raises PT on InterMune Awaiting Inflection Point 9:35 a.m. July 25, 2013 - benzinga.com
Morgan Stanley Reiterates Equal-Weight Rating on InterMune Following 2Q Sales Results 7:56 a.m. July 25, 2013 - benzinga.com
InterMune Inc. (ITMN) CEO Discusses Q2 2013 Results - Earnings Call Transcript 9:32 p.m. July 24, 2013 - Seeking Alpha
Array BioPharma Remains Undiscovered Gem In Cancer Treatment Industry 2:58 p.m. July 18, 2013 - Seeking Alpha
1 Stock to Buy, 1 Stock to Short: Biotech 6:52 a.m. June 20, 2013 - InvestorPlace.com
MSPD, ITMN, CYTX and VRNG added to NASDAQ Active Stock Watch List at EPR 10:11 a.m. Nov. 6, 2013 - ACCESSWIRE
Financial Results and Upcoming Conference Calls - Research Report on Ariad, Idenix, Osiris, InterMune, and Array BioPharma 8:00 a.m. Nov. 6, 2013 - PR Newswire
InterMune Announces Pricing of Public Offering of 6,500,000 Shares of Common Stock 9:25 p.m. Nov. 5, 2013 - PR Newswire
InterMune Announces Proposed Public Offering of Common Stock 4:00 p.m. Nov. 4, 2013 - PR Newswire
Under AAAResearchReports.com Microscope: Gilead Sciences Inc., NPS Pharma Inc., Halozyme Therapeutics Inc., and InterMune Inc. 11:14 a.m. Nov. 4, 2013 - PR Newswire
InterMune Reports Third Quarter 2013 Financial Results And Business Highlights 3:00 p.m. Oct. 30, 2013 - PR Newswire
Partnership, Quarterly Reports, Acquisition, and Publication - Research Report on Alere, Ironwood, Magellan Health Services, Foundation Medicine, and InterMune 8:00 a.m. Oct. 28, 2013 - PR Newswire
InterMune To Release Third Quarter Financial Results On October 30 7:00 a.m. Oct. 23, 2013 - PR Newswire
Technical Study: Gilead Sciences Inc., NPS Pharmaceuticals Inc., Halozyme Therapeutics Inc., and InterMune Inc. 8:28 a.m. Oct. 11, 2013 - PR Newswire
Regulatory Approval, New Appointments, Stock Price Movements, and Other Announcements - Research Report on Pfizer, Warner Chilcott, Rockwell Medical, InterMune, and Ligand 7:00 a.m. Oct. 2, 2013 - PR Newswire
Andrew Powell Joins InterMune As Executive Vice President And General Counsel 7:00 a.m. Sept. 24, 2013 - PR Newswire
Vital Therapies, Inc. Expands Board of Directors 5:01 a.m. Sept. 20, 2013 - Marketwire
Idiopathic pulmonary fibrosis (IPF) community emphasizes the power of united support for patients during IPF World Week 2013 11:01 p.m. Sept. 19, 2013 - PR Newswire
Technical Study: Gilead Sciences Inc., Halozyme Therapeutics Inc., NPS Pharmaceuticals Inc., and InterMune Inc. 10:22 a.m. Sept. 12, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 8:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Galectin Therapeutics Receives Fast Track Designation from FDA for New Fibrosis Drug 12:40 p.m. Aug. 14, 2013 - ACCESSWIRE
Galectin Therapeutics Lab Studies Shows Robust Results in Treating Lung Fibrosis 10:35 a.m. Aug. 6, 2013 - ACCESSWIRE
Early Briefing and Review: Gilead Sciences, InterMune, NPS Pharma, and Halozyme Therapeutics 7:00 a.m. Aug. 6, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALNY, BCRX, ITMN and SRPT 7:41 a.m. July 31, 2013 - ACCESSWIRE
New License Agreements and Financial Results Release - Research Report on Elan, Waters, InterMune, Spectranetics, and Ligand 7:00 a.m. July 29, 2013 - PR Newswire
Biogen, InterMune, Alkermes all make stock waves with earnings 1:28 p.m. July 25, 2013 - Russ Britt
Hedge funds are buying these stocks 3:41 p.m. April 26, 2013 - Insider Monkey
Market post-mortem: Big biotechs spike as Street warming to firms 4:43 p.m. April 12, 2013 - Russ Britt
InterMune shares jump after U.K. regulator recommends key drug 9:44 a.m. March 21, 2013 - Russ Britt
Thursday’s biggest movers; Apple at 5-month low 5:27 p.m. Nov. 8, 2012 - Sue Chang
Wednesday’s biggest gaining and declining stocks 3:32 p.m. Oct. 3, 2012 - MarketWatch
Stocks to watch Tuesday: Nordson, Georgia Gulf 5:40 a.m. May 22, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 3:19 p.m. April 9, 2012 - Kate Gibson
InterMune: Light at the end of the tunnel? 2:31 p.m. April 9, 2012 - blogs.marketwatch.com
InterMune tumbles on study update 11:27 a.m. April 9, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining & declining stocks 3:34 p.m. March 15, 2012 - Kate Gibson
InterMune climbs on German regulatory update 11:28 a.m. March 15, 2012 - Val Brickates Kennedy
InterMune shares climb on German regulatory nod 10:16 a.m. March 15, 2012 - MarketWatch.com
InterMune slides for second day 11:58 a.m. Dec. 16, 2011 - Val Brickates Kennedy
InterMune plunges 21% in midday action 12:27 p.m. Dec. 15, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 3:36 p.m. Sept. 13, 2011 - Kate Gibson
InterMune tumbles 9% on stock offering 10:33 a.m. Sept. 13, 2011 - Val Brickates Kennedy
Stocks to watch Tuesday: Best Buy, Intersil 5:51 a.m. Sept. 13, 2011 - MarketWatch
3 biotech stocks battle the ‘Dendreon Effect’ 6:50 p.m. Aug. 18, 2011 - Val Brickates Kennedy
Biotech analysts see plunge as buying opportunity 1:35 p.m. Aug. 12, 2011 - Val Brickates Kennedy
Heavy Early Morning Activity On InterMune (ITMN) 8:47 a.m. Nov. 6, 2013 - TheStreet.com
InterMune Prices 6.5M Share Offering at $13.00/Share 8:41 p.m. Nov. 5, 2013 - benzinga.com
InterMune Announces 6.5M Share Offering 3:05 p.m. Nov. 4, 2013 - benzinga.com
10-Q: INTERMUNE INC 4:02 p.m. Nov. 1, 2013 - Edgar Online - (EDG = 10Q, 10K)
Two Speculative Biotech Stocks 10:00 a.m. Oct. 31, 2013 - RealMoney.com
Narrower-than-Expected Q3 Loss at InterMune - Analyst Blog 9:10 a.m. Oct. 31, 2013 - Zacks.com
InterMune's CEO Discusses Q3 2013 Results - Earnings Call Transcript 6:51 p.m. Oct. 30, 2013 - Seeking Alpha
InterMune, Inc. Discusses Q3 2013 Results (Webcast) 3:25 p.m. Oct. 30, 2013 - Seeking Alpha
Will Pfizer (PFE) Disappoint this Earnings? - Analyst Blog 11:50 a.m. Oct. 28, 2013 - Zacks.com
Jim Cramer: Buy Facebook, Express, and This Hot Stock 8:34 a.m. Sept. 13, 2013 - Wall St. Cheat Sheet
Cramer's Lightning Round - We Bought A Ton Of Facebook (9/12/13) 2:57 a.m. Sept. 13, 2013 - Seeking Alpha
UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013 6:40 a.m. Sept. 4, 2013 - 247WallSt.com
10-Q: INTERMUNE INC 4:18 p.m. Aug. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
InterMune Successfully Entering Huge Niche Market Unchallenged 9:37 a.m. July 28, 2013 - Seeking Alpha
Narrower-than-Expected Loss at InterMune - Analyst Blog 4:29 p.m. July 25, 2013 - Zacks.com
UPDATE: Stifel Nicolaus Raises PT on InterMune Awaiting Inflection Point 9:35 a.m. July 25, 2013 - benzinga.com
Morgan Stanley Reiterates Equal-Weight Rating on InterMune Following 2Q Sales Results 7:56 a.m. July 25, 2013 - benzinga.com
InterMune Inc. (ITMN) CEO Discusses Q2 2013 Results - Earnings Call Transcript 9:32 p.m. July 24, 2013 - Seeking Alpha
Array BioPharma Remains Undiscovered Gem In Cancer Treatment Industry 2:58 p.m. July 18, 2013 - Seeking Alpha
1 Stock to Buy, 1 Stock to Short: Biotech 6:52 a.m. June 20, 2013 - InvestorPlace.com
MSPD, ITMN, CYTX and VRNG added to NASDAQ Active Stock Watch List at EPR 10:11 a.m. Nov. 6, 2013 - ACCESSWIRE
Financial Results and Upcoming Conference Calls - Research Report on Ariad, Idenix, Osiris, InterMune, and Array BioPharma 8:00 a.m. Nov. 6, 2013 - PR Newswire
InterMune Announces Pricing of Public Offering of 6,500,000 Shares of Common Stock 9:25 p.m. Nov. 5, 2013 - PR Newswire
InterMune Announces Proposed Public Offering of Common Stock 4:00 p.m. Nov. 4, 2013 - PR Newswire
Under AAAResearchReports.com Microscope: Gilead Sciences Inc., NPS Pharma Inc., Halozyme Therapeutics Inc., and InterMune Inc. 11:14 a.m. Nov. 4, 2013 - PR Newswire
InterMune Reports Third Quarter 2013 Financial Results And Business Highlights 3:00 p.m. Oct. 30, 2013 - PR Newswire
Partnership, Quarterly Reports, Acquisition, and Publication - Research Report on Alere, Ironwood, Magellan Health Services, Foundation Medicine, and InterMune 8:00 a.m. Oct. 28, 2013 - PR Newswire
InterMune To Release Third Quarter Financial Results On October 30 7:00 a.m. Oct. 23, 2013 - PR Newswire
Technical Study: Gilead Sciences Inc., NPS Pharmaceuticals Inc., Halozyme Therapeutics Inc., and InterMune Inc. 8:28 a.m. Oct. 11, 2013 - PR Newswire
Regulatory Approval, New Appointments, Stock Price Movements, and Other Announcements - Research Report on Pfizer, Warner Chilcott, Rockwell Medical, InterMune, and Ligand 7:00 a.m. Oct. 2, 2013 - PR Newswire
Andrew Powell Joins InterMune As Executive Vice President And General Counsel 7:00 a.m. Sept. 24, 2013 - PR Newswire
Vital Therapies, Inc. Expands Board of Directors 5:01 a.m. Sept. 20, 2013 - Marketwire
Idiopathic pulmonary fibrosis (IPF) community emphasizes the power of united support for patients during IPF World Week 2013 11:01 p.m. Sept. 19, 2013 - PR Newswire
Technical Study: Gilead Sciences Inc., Halozyme Therapeutics Inc., NPS Pharmaceuticals Inc., and InterMune Inc. 10:22 a.m. Sept. 12, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 8:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Galectin Therapeutics Receives Fast Track Designation from FDA for New Fibrosis Drug 12:40 p.m. Aug. 14, 2013 - ACCESSWIRE
Galectin Therapeutics Lab Studies Shows Robust Results in Treating Lung Fibrosis 10:35 a.m. Aug. 6, 2013 - ACCESSWIRE
Early Briefing and Review: Gilead Sciences, InterMune, NPS Pharma, and Halozyme Therapeutics 7:00 a.m. Aug. 6, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALNY, BCRX, ITMN and SRPT 7:41 a.m. July 31, 2013 - ACCESSWIRE
New License Agreements and Financial Results Release - Research Report on Elan, Waters, InterMune, Spectranetics, and Ligand 7:00 a.m. July 29, 2013 - PR Newswire
(0)
(0)